We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Economic Evaluation of Heart Failure Management in Colombian Clinics (EconoHeart)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01084564
First Posted: March 10, 2010
Last Update Posted: March 10, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
AstraZeneca
March 9, 2010
March 10, 2010
March 10, 2010
January 2008
June 2008   (Final data collection date for primary outcome measure)
  • To determine cost-effectiveness of Heart Failure management in 3 Heart-specialized clinics in Bogotá Colombia [ Time Frame: 12 months ]
  • Incremental cost-effectiveness ratio from using Symbicort as symbicort as Maintenance and Reliever Therapy (SMART) when compared with its competitive alternatives
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Economic Evaluation of Heart Failure Management in Colombian Clinics
Economic Evaluation of Heart Failure Management in Colombian Clinics
Cost effectiveness analysis of local management of patients diagnosed with heart failure disease compared with an ideal guideline-based management.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Retrospective
Not Provided
Not Provided
Probability Sample
Moderate to severe uncontrolled asthma.
  • Heart Failure
  • Asthma
Not Provided
1
moderate to severe uncontrolled asthma
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
300
June 2008
June 2008   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Asthma moderate to severe.
Sexes Eligible for Study: All
18 Years to 65 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT01084564
NIS-CCO-ATA-2007/1
No
Not Provided
Not Provided
MC MD, AstraZeneca
AstraZeneca
Not Provided
Study Director: Rodolfo Dennis, M.D. Pontificia Universidad Javeriana
Principal Investigator: MARÍA XIMENA ROJAS, M.D. Pontificia Universidad Javeriana
AstraZeneca
March 2010